NPPA warns pharmaceutical companies for ceiling prices of coronary stents
According to the Ministry, NPPA noticed that some companies sell the ower priced stent at higher prices thereby giving more than 8% trade margins.
NPPA issue came in after few companies dealing with coronary stents rolled out freebies. Photo: Zeebiz team